Arian Frasheri

959 total citations
17 papers, 662 citations indexed

About

Arian Frasheri is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arian Frasheri has authored 17 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arian Frasheri's work include Coronary Interventions and Diagnostics (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Arian Frasheri is often cited by papers focused on Coronary Interventions and Diagnostics (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Arian Frasheri collaborates with scholars based in Italy, Switzerland and Spain. Arian Frasheri's co-authors include Manfredi Rizzo, Vincenzo Pernice, Kaspar Berneis, Antonio Colombo, J. Domínguez, Neus Salvatella, Patrizia Presbitero, Gennaro Giustino, Giuseppe Tarantini and Alberto Menozzi and has published in prestigious journals such as Journal of the American College of Cardiology, International Journal of Cancer and Heart.

In The Last Decade

Arian Frasheri

17 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arian Frasheri Italy 9 517 401 127 111 89 17 662
Akihide Konishi Japan 12 431 0.8× 338 0.8× 212 1.7× 91 0.8× 212 2.4× 52 669
Tsuyoshi Osue Japan 13 462 0.9× 322 0.8× 192 1.5× 109 1.0× 198 2.2× 28 664
Shih‐Pu Wang Taiwan 17 213 0.4× 639 1.6× 80 0.6× 26 0.2× 99 1.1× 47 758
Vimal Mehta India 15 202 0.4× 357 0.9× 116 0.9× 37 0.3× 94 1.1× 62 566
Masamichi Iwasaki Japan 14 475 0.9× 361 0.9× 180 1.4× 92 0.8× 262 2.9× 53 696
Maria João Ferreira Portugal 13 125 0.2× 312 0.8× 87 0.7× 55 0.5× 219 2.5× 85 574
Masaomi Gohbara Japan 11 138 0.3× 333 0.8× 55 0.4× 188 1.7× 117 1.3× 46 505
Hiroto Kinutani Japan 14 374 0.7× 412 1.0× 346 2.7× 82 0.7× 142 1.6× 31 695
Turhan Turan Türkiye 13 148 0.3× 218 0.5× 56 0.4× 25 0.2× 68 0.8× 60 391
Itaru Takamisawa Japan 12 196 0.4× 427 1.1× 155 1.2× 54 0.5× 104 1.2× 80 622

Countries citing papers authored by Arian Frasheri

Since Specialization
Citations

This map shows the geographic impact of Arian Frasheri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arian Frasheri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arian Frasheri more than expected).

Fields of papers citing papers by Arian Frasheri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arian Frasheri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arian Frasheri. The network helps show where Arian Frasheri may publish in the future.

Co-authorship network of co-authors of Arian Frasheri

This figure shows the co-authorship network connecting the top 25 collaborators of Arian Frasheri. A scholar is included among the top collaborators of Arian Frasheri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arian Frasheri. Arian Frasheri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Braschi, Annabella, et al.. (2023). Erythrocyte Indices in Patients With Takotsubo Syndrome. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 22(1). 31–39. 1 indexed citations
2.
Braschi, Annabella, et al.. (2020). Association between Tpeak-Tend/QT and major adverse cardiovascular events in patients with Takotsubo syndrome. Acta cardiologica. Supplementum. 76(7). 732–738. 14 indexed citations
4.
Colombo, Antonio, Alaide Chieffo, Arian Frasheri, et al.. (2014). Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy. Journal of the American College of Cardiology. 64(20). 2086–2097. 274 indexed citations
5.
Rizzo, Manfredi, et al.. (2009). LDL size and subclasses in patients with abdominal aortic aneurysm. International Journal of Cancer. 134. 406–408. 1 indexed citations
6.
Rizzo, Manfredi, Vincenzo Pernice, Arian Frasheri, et al.. (2008). Small, dense low‐density lipoproteins (LDL) are predictors of cardio‐ and cerebro‐vascular events in subjects with the metabolic syndrome. Clinical Endocrinology. 70(6). 870–875. 91 indexed citations
7.
Rizzo, Manfredi, Vincenzo Pernice, Arian Frasheri, et al.. (2008). Small, dense low-density lipoproteins are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome.. Nova Science Publishers (Nova Science Publishers, Inc.). 9. 13 indexed citations
8.
Rizzo, Manfredi, Vincenzo Pernice, Arian Frasheri, & Kaspar Berneis. (2007). Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis. 197(1). 237–241. 61 indexed citations
9.
Barbagallo, Carlo M., Manfredi Rizzo, Davide Noto, et al.. (2006). Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease. Metabolism. 55(5). 662–668. 18 indexed citations
10.
Rizzo, Manfredi, Carlo M. Barbagallo, Davide Noto, et al.. (2005). Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study. Nutrition Metabolism and Cardiovascular Diseases. 15(5). 361–367. 8 indexed citations
11.
Albiero, Remo, Sigmund Silber, Carlo Di Mario, et al.. (2004). Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis. Journal of the American College of Cardiology. 43(6). 943–949. 146 indexed citations
12.
Barbagallo, Carlo M., Davide Noto, A Rubino, et al.. (2004). Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study. Nova Science Publishers (Nova Science Publishers, Inc.). 361–367. 1 indexed citations
13.
Gulizia, Michele Massimo, et al.. (2004). [Potential impact of drug-eluting stents in Sicily: results from a multicenter survey and cost-benefit analysis of drug-eluting stents versus bare metal stents].. PubMed. 5(8). 630–8. 2 indexed citations
14.
Barbagallo, Carlo M., Manfredi Rizzo, Cecilia Camarda, et al.. (2004). Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors.. 4. 157–162. 1 indexed citations
15.
Airoldi, Flavio, Carlo Di Mario, Giorgio Gimelli, et al.. (2003). A randomized comparison of direct stenting versus stenting with predilatation in native coronary artery disease: results from the multicentric Crosscut study.. PubMed. 15(1). 1–5. 9 indexed citations
16.
Airoldi, Flavio, Carlo Di Mario, Patrizia Presbitero, et al.. (2002). Elective stenting in small coronary arteries: results of the Italian prospective multicenter registry MICROSCOPE.. PubMed. 3(7). 406–11. 2 indexed citations
17.
Goda, Artan, et al.. (1988). Acute haemodynamic effects of nifedipine in patients with ventricular septal defect.. Heart. 60(2). 149–155. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026